SCHEMBL5119009

SCHEMBL5119009

CNC(=O)c1nccc2c1ncn2-c1ccc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 8/20 0.59
▸ BRAF P15056 7/20 0.56
▸ RAF1 P04049 7/20 0.56
▸ RET P07949 3/20 0.56
▸ KIT P10721 3/20 0.56
▸ FLT3 P36888 3/20 0.56
▸ RIPK2 O43353 2/20 0.56
▸ ABCB11 O95342 2/20 0.56
▸ ABL1 P00519 2/20 0.56
▸ HTR1A P08908 2/20 0.56
▸ PDGFRB P09619 2/20 0.56
▸ ADORA3 P0DMS8 2/20 0.56
▸ FGFR1 P11362 2/20 0.56
▸ PDGFRA P16234 2/20 0.56
▸ FLT1 P17948 2/20 0.56
▸ MAOA P21397 2/20 0.56
▸ EPHA1 P21709 2/20 0.56
▸ TBXA2R P21731 2/20 0.56
▸ EPHA2 P29317 2/20 0.56
▸ TTK P33981 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14191809 0.91 KDR (0.53) KDRBRAFRAF1RETKIT
Hydrochloric Acid SCHEMBL5114832 0.90 KDR (0.52) KDRBRAFRAF1RETKIT
SCHEMBL5120746 0.90 KDR (0.54) KDRBRAFRAF1RETKIT
SCHEMBL5104724 0.88 KDR (0.53) KDRBRAFRAF1RETKIT
SCHEMBL5110320 0.88 KDR (0.56) KDRBRAFRAF1RETKIT
SCHEMBL5140054 0.87 ATM (0.49) KDRBRAFRAF1
Hydrochloric Acid SCHEMBL5105086 0.86 RAF1 (0.52) KDRBRAFRAF1RETKIT
SCHEMBL5111916 0.86 KDR (0.55) KDRBRAFRAF1RETKIT
Hydrochloric Acid SCHEMBL5114838 0.86 RAF1 (0.50) KDRBRAFRAF1RETKIT
SCHEMBL5120556 0.86 RIPK1 (0.59) KDRBRAFRAF1KITPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609656-B2 Heteroarylphenylurea derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2013-12-17 — — US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed
EP-1724258-A1 HETEROARYLPHENYLUREA DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-11-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119466-A1 Heteroarylphenylurea Derivative CHRM1, CBR3, CHRM2 KDR 2440/4885BRAF 1735/4885RAF1 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback